124 STAT. 733 PUBLIC LAW 111–148—MAR. 23, 2010 comparative clinical effectiveness research methods (determined as of the date of enactment of the Patient Protection and Affordable Care Act). ‘‘(ii) A translation table that is designed to provide guidance and act as a reference for the Board to deter- mine research methods that are most likely to address each specific research question. ‘‘(D) CONSULTATION AND CONDUCT OF EXAMINATIONS.— The methodology committee may consult and contract with the Institute of Medicine of the National Academies and academic, nonprofit, or other private and governmental entities with relevant expertise to carry out activities described in subparagraph (C) and may consult with rel- evant stakeholders to carry out such activities. ‘‘(E) REPORTS.—The methodology committee shall submit reports to the Board on the committee’s performance of the functions described in subparagraph (C). Reports shall contain recommendations for the Institute to adopt methodological standards developed and updated by the methodology committee as well as other actions deemed necessary to comply with such methodological standards. ‘‘(7) PROVIDING FOR A PEER-REVIEW PROCESS FOR PRIMARY RESEARCH.— ‘‘(A) IN GENERAL.—The Institute shall ensure that there is a process for peer review of primary research described in subparagraph (A)(ii) of paragraph (2) that is conducted under such paragraph. Under such process— ‘‘(i) evidence from such primary research shall be reviewed to assess scientific integrity and adherence to methodological standards adopted under paragraph (9); and ‘‘(ii) a list of the names of individuals contributing to any peer-review process during the preceding year or years shall be made public and included in annual reports in accordance with paragraph (10)(D). ‘‘(B) COMPOSITION.—Such peer-review process shall be designed in a manner so as to avoid bias and conflicts of interest on the part of the reviewers and shall be com- posed of experts in the scientific field relevant to the research under review. ‘‘(C) USE OF EXISTING PROCESSES.— ‘‘(i) PROCESSES OF ANOTHER ENTITY.—In the case where the Institute enters into a contract or other agreement with another entity for the conduct or management of research under this section, the Institute may utilize the peer-review process of such entity if such process meets the requirements under subparagraphs (A) and (B). ‘‘(ii) PROCESSES OF APPROPRIATE MEDICAL JOUR- NALS.—The Institute may utilize the peer-review process of appropriate medical journals if such process meets the requirements under subparagraphs (A) and (B). ‘‘(8) RELEASE OF RESEARCH FINDINGS.— ‘‘(A) IN GENERAL.—The Institute shall, not later than 90 days after the conduct or receipt of research findings under this part, make such research findings available Deadline. Lists. Public information. Recommenda- tions.
